Clinical Trials in Minneapolis

Showing 4841-4860 of 14,456 trials

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

NCT03165526

FDA issued a Humanitarian Device Exemption (HDE) approval order for the AMPLATZER™ PIVSD Occluder (H070005) on January 10, 2017. The Conditions of Approval require that SJM conduct a post approval study to evaluate the safety and probable benefit of the AMPLATZER™ PIVSD Occluder.

Post-Infarction Ventricular Septal Defect

Abbott Medical Devices131 participantsStarted Oct 2018

San Francisco, California, United States • Gainesville, Florida, United States • Baltimore, Maryland, United States +14 more locations

Active Not Recruiting< 1 mile

COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial

NCT03214029

Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.

Acute Myocardial InfarctionAcute Coronary Syndrome

Hennepin Healthcare Research Institute2,000 participantsStarted Nov 2017

Minneapolis, Minnesota, United States

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial

Find Trials by Condition in Minneapolis

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Diabetes Homelessness Medication Support Program in Spanish

MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.

Health Promotion of People With Disabilities

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

REmodeling the Left Ventricle With Atrial Modulated Pacing

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

Wearable Assessments in the Clinic and Home in PD

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)